A GLP-1/glucagon (GCG)/CCK2 receptors tri-agonist provides new therapy for obesity and diabetes
(3) Lose weight at 0.5-1% body weight per week maximum
Structural features such as fatty acid conjugation and sequence modifications may extend the peptide's stability and allow it to remain active longer in experimental environments, which is relevant to pharmacokinetic studies examining receptor occupancy and downstream signaling duration
Our formula combines GHK-Cu with three additional active compounds: tretinoin (prescription-strength vitamin A derivative) for cell turnover and collagen synthesis, estriol for skin elasticity and hydration, and niacinamide for barrier function and inflammation control
This raises the risk of serious side effects, including bone loss, high blood sugar, weight gain, and adrenal suppression
I cant wait for you to try it